Patents by Inventor Amy C. Dearking

Amy C. Dearking has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endoluminal Implants For Bioactive Material Delivery
    Publication number: 20100131043
    Abstract: Disclosed herein are endoluminal implants for bioactive material delivery. The disclosed endoluminal implants come in the general forms of patches and sleeves and can deliver bioactive materials independently of other implantable medical devices such as stents.
    Type: Application
    Filed: November 26, 2008
    Publication date: May 27, 2010
    Inventors: Jesus W. Casas, Amy C. Dearking, Rodolfo Padua, Molly Schiltgen, Jeffrey P. Walker
  • IDENTIFYING PATIENTS AT RISK FOR LIFE THREATENING ARRHYTHMIAS
    Publication number: 20100047915
    Abstract: The invention is a method for identifying proteins associated with sudden cardiac death (SCD) and for assessing a patient's risk of SCD by determining the amount of one or more SCD-associated proteins in the patient. Typically, the patient submits a sample, such as a blood sample, which is tested for one or more SCD-associated proteins. Based upon the results of the tests, the patient's risk of SCD may be assessed.
    Type: Application
    Filed: October 26, 2009
    Publication date: February 25, 2010
    Applicant: MEDTRONIC, INC.
    Inventors: Orhan Soykan, Amy C. Dearking, Timothy H. Robinson, Walter H. Olson, Vinod Sharma
  • Methods for identifying patients at risk for life threatening arrhythmias
    Patent number: 7622303
    Abstract: In general, the invention is directed to systems and techniques for assessing a risk of ventricular tachyarrhythmia in a patient by measuring one or more biochemical markers that reflect the health of a patient. Typically, the patient submits a sample, such as a blood sample, which is tested for one or more biomarkers. Based upon the results of the tests, the patient's risk of ventricular tachyarrhythmia may be assessed. When the patient is found to be at risk, the patient may receive an implantable medical device or drug therapy to address the risk.
    Type: Grant
    Filed: February 3, 2005
    Date of Patent: November 24, 2009
    Assignee: Medtronic, Inc.
    Inventors: Orhan Soykan, Timothy H. Robinson, Walter H. Olson, Vinod Sharma, Amy C. Dearking
  • Identifying patients at risk for life threatening arrhythmias
    Patent number: 7608458
    Abstract: The invention is a method for identifying proteins associated with sudden cardiac death (SCD) and for assessing a patient's risk of SCD by determining the amount of one or more SCD-associated proteins in the patient. Typically, the patient submits a sample, such as a blood sample, which is tested for one or more SCD-associated proteins. Based upon the results of the tests, the patient's risk of SCD may be assessed.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: October 27, 2009
    Assignee: Medtronic, Inc.
    Inventors: Orhan Soykan, Amy C. Dearking, Timothy H. Robinson, Walter H. Olson, Vinod Sharma